Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder

Neha Sharmaa, Swetlana Gautama, Uma Devib, Manjari Singha, Jitendra K. Rawata, Nikunj Sethic, Shubhini A. Sarafa and Gaurav Kaithwas*a
aDepartment of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226 025, U.P., India. E-mail: gauravpharm@hotmail.com; Tel: +91-9670204349
bDepartment of Pharmaceutical Sciences, Faculty of Health Medical Sciences Indigenous and Alternative Medicine, SHIATS-Deemed to be University Formerly Allahabad Agricultural Institute, Naini, Allahabad, U.P., India
cInstitute of Pharmacy, Chatrapati Sahuji Maharaj University, Kanpur-208024, India

Received 30th November 2015 , Accepted 30th November 2015

First published on 11th December 2015


Abstract

Correction for ‘Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder’ by Neha Sharma et al., RSC Adv., 2015, 5, 39003–39011.


The authors regret that incorrect details were presented for the sixth author's affiliation in the original article. Affiliation ‘c’, at which the author carried out the work reported in the original article, is herein amended to ‘Institute of Pharmacy, Chatrapati Sahuji Maharaj University, Kanpur-208024, India’.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.